Publication details

Circulating miR-378 is increase in blood serum of renal cell carcinoma patients



Year of publication 2013
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Description Renal cell carcinoma is the most common neoplasm of adult kidney, having the highest mortality rate at over 40%. Renal tumors are commonly asymptomatic in early stages and although surgical resection remains the best therapy, after the curative nephrectomy 20-40% of patients will develop recurrence. Our aim was to identify serum biomarkers, which could be used for diagnosis or early detection of recurrence in renal cell carcinoma patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info